Deconstructing the Evolution of Metastasis

The Evomet research project aims to transform how cancer metastasis is understood and treated

6 – 8th November 2024 | Brussels (Belgium)

What’s new? Keep track of Evomet’s progress on the News page!

EVOMET's Motion Graphics is here! Co-created by our ESRs, we present to you a quick overview of what our project is [...]

The 2nd Annual Meeting of EVOMET took place in Basel, Switzerland between the 4th to the 7th of October 2022. It was [...]

A University of Lausanne study has developed a strategy to noninvasively track immune cells known as macrophages within brain and breast tumors [...]

Evomet is an Innovative Training Network (ITN) with a mission to train Early Stage Researchers in metastasis progression.

Evomet comprises several of the best academic, clinical and industrial entities in cancer and metastasis research in Europe.

Evomet comprises several of the best academic, clinical and industrial entities in cancer and metastasis research in Europe.

Evomet leverages basic research on the evolution of metastatic cancers to impact drug development and the clinical standard of care.

Cell Fate – WP1

Environment – WP2

Latency – WP3

Expansion – WP4

Cell Fate – WP1

Environment – WP2

Latency – WP3

Expansion – WP4